Huntington's disease: progress and potential in the field

Author： Stack Edward C Ferrante Robert J

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.12, 2007-12, pp. : 1933-1953

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease

By S. Brocardo Patricia M. Gil-Mohapel Joana

Current Psychopharmacology, Vol. 2, Iss. 2, 2013-05 ,pp. : 113-131

Bentham Science Publishers

Access to resources Recommend Favorite

Mouse models of Huntington's disease

By Menalled L.B. Chesselet M.-F.

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 32-39

Elsevier

Access to resources Recommend Favorite

The Endocannabinoid System and Huntington's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 335-347

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotection in Huntington;s Disease

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 143-147

Bentham Science Publishers

Access to resources Recommend Favorite

Combination therapy with olanzapine plus valproate: potential in Huntington's disease?

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite